Pharmacokinetic/pharmacodynamic relationships of FTY720 in kidney transplant recipients gan S.I. Park, C.R. Felipe, P.G. Machado, R. Garcia, A. Skerjanec, R. Schmouder, H. Tedesco-Silva Jr., J.O. Medina-Pestana

Cael y testun llawn

Exploratory calcineurin inhibitor-free regimens in living-related kidney transplant recipients gan R. Garcia, P.G. Machado, C.R. Felipe, S.I. Park, G.A. Spinelli, M.F. Franco, H. Tedesco-Silva Jr., J.O. Medina-Pestana

Cael y testun llawn

Impact of initial exposure to calcineurin inhibitors on kidney graft function of patients at high risk to develop delayed graft function gan L.A. Silva, C.R. Felipe, S.I. Park, P. Pinheiro-Machado, R. Garcia, M. Franco, S.R. Moreira, H. Tedesco-Silva Jr., J. Medina-Pestana

Cael y testun llawn

Preservation of graft function in low-risk living kidney transplant recipients treated with a combination of sirolimus and cyclosporine gan P.G.P. Machado, C.R. Felipe, S.I. Park, R. Garcia, S. Moreira, D. Casarini, M. Franco, F. Alfieri, H. Tedesco-Silva Jr., J.O. Medina-Pestana

Cael y testun llawn

Relationship of cyclosporin and sirolimus blood concentrations regarding the incidence and severity of hyperlipidemia after kidney transplantation gan G.A. Spinelli, C.R. Felipe, P.G. Machado, R. Garcia, D.E. Casarini, S.R. Moreira, S.I. Park, H. Tedesco-Silva Jr., J.O. Medina-Pestana

Cael y testun llawn